NewEdge Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
NewEdge Advisors's REVS Position: Q2 2026 in Review
NewEdge Advisors reduced its Columbia Research Enhanced Value ETF (REVS) stake by 47% in Q2 2026, selling an estimated $1.4M and leaving 51,321 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1338.
NewEdge Advisors first reported a position in REVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.15M in Q4 2022. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- NewEdge Advisors held 51,321 shares of Columbia Research Enhanced Value ETF worth $1.61M as of Q2 2026.
- NewEdge Advisors sold 45,597 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.4M.
- Columbia Research Enhanced Value ETF made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1338 holding.
- NewEdge Advisors first reported a position in Columbia Research Enhanced Value ETF in Q4 2022 and has held it in 15 quarters since.
- NewEdge Advisors's Columbia Research Enhanced Value ETF position peaked at $5.15M in Q4 2022.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.